Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine
- 1 October 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 26 (4) , 852-858
- https://doi.org/10.1016/0735-1097(95)00286-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjectsThe American Journal of Cardiology, 1994
- Comparative effects of the combination of digoxin and dl-sotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillationAmerican Heart Journal, 1994
- Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillationThe American Journal of Cardiology, 1993
- Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmiasAmerican Heart Journal, 1992
- Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythmThe American Journal of Cardiology, 1986
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Diltiazem, Verapamil, and Quinidine in Patients With Chronic Atrial FibrillationThe Journal of Clinical Pharmacology, 1985
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- The use of quinidine in cardioversionThe American Journal of Cardiology, 1967
- Quinidine SyncopeCirculation, 1964